-
Subscribe
for Free
-
-
Our
Cities▾
-
Tech
Channels ▾
-
Meet the
Xconomists ▾
-
CEO and Founder, TechStars
-
Chairman, CEO, Acucela
-
Professor of Molecular Biology, Rockefeller University
-
Nobel Laureate, Professor of Biology, Caltech
-
Meet All the Xconomists ›
-
Professor of Chemistry, Tufts University
-
Founder and President, North Coast Biologics
-
General Partner, Frazier Healthcare
-
Co-Founder and CEO, Genoptix
-
Our
Events ▾
-
|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Icahn Blasts Genzyme Manufacturing, Glaxo Halts “Red Wine” Drug Trial, Ariad Gets $69M from Merck, & More Boston-Area Life Sciences News
|
Erin Kutz |
05/07/10 |
Boston
|
|
$2B Stock Buyback for Genzyme
|
Erin Kutz |
05/06/10 |
Boston
|
|
Icahn Calls Genzyme’s Manufacturing “Broken,” Advises Against Termeer’s Re-Election to Board
|
Ryan McBride |
05/04/10 |
Boston
|
|
Genzyme Activist Joins Board, Agios Clinches Deal With Celgene, Third Rock Seeks $400M New Fund, & More Boston-Area Life Sciences News
|
Erin Kutz |
04/16/10 |
Boston
|
|
Genzyme Adds Whitworth to Board, WSJ Says
|
Luke Timmerman |
04/14/10 |
Boston
|
|
Biogen Idec Reaches Deal With Icahn, Ironwood CEO Shares IPO Strategy, Luke Maps out the Genetics Institute Diaspora, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
03/26/10 |
Boston
|
|
Icahn Gets One More Seat on Biogen Board
|
Ryan McBride |
03/22/10 |
Boston
|
|
Biogen Idec Seeks Science-Savvy CEO, LifeImage Partners With EMC, GenomeQuest Aims to be Genetic Google, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
02/26/10 |
Boston
|
|
Icahn Making His Move On Genzyme
|
Ryan McBride |
02/22/10 |
Boston
|
|
Chairman Bill Young: Next Biogen Idec CEO May Be a Scientist
|
Luke Timmerman |
02/22/10 |
Boston
|
|
Sirtris Founders Resurface with New Fund, Icahn Continues to Make Biotech Waves, Sentillion Bought by Microsoft, & More Boston-Area Life Sciences News
|
Erin Kutz |
02/19/10 |
Boston
|
|
Icahn Boosts Genzyme Stake
|
Ryan McBride |
02/16/10 |
Boston
|
|
Carl Icahn Nominates Scripps Researcher to Biogen Idec Board, BrainCells Pursues New Drug Combo for Depression, Illumina Adds to Oxford Nanopore Investment, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
02/04/10 |
San Diego
|
|
All Eyes On Ironwood IPO, Icahn Seeks Biogen Board Seats, Boston Scientific Settles with J&J, & More Boston-Area Life Sciences News
|
Erin Kutz |
02/03/10 |
Boston
|
|
Carl Icahn Nominates Three More Candidates for Biogen Board Seats
|
Ryan McBride |
01/28/10 |
Boston
|
|
Motricity Files for IPO
|
Gregory T. Huang |
01/22/10 |
Seattle
|
|
6 Goals for Fixing Genzyme: Xconomy’s Q&A With Relational Investors’ Ralph Whitworth
|
Bruce V. Bigelow |
01/21/10 |
San Diego
|
|
Agreement Between Genzyme and San Diego Activist Shareholder Suggests Truce
|
Bruce V. Bigelow |
01/07/10 |
San Diego
|
|
Biogen Idec CEO Stepping Down, Ambrx Focuses on Empowered Antibodies, Intellikine Testing First Drug Candidate, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
01/07/10 |
San Diego
|
|
Mullen to Relinquish Biogen Idec Reins, Joule to Test Ethanol Tech, Dicerna to Team with Kyowa Hakko Kirin, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
01/06/10 |
Boston
|
|
Biogen Idec CEO Jim Mullen Stepping Down, After Tumultuous Year of Shareholder Activism
|
Luke Timmerman |
01/04/10 |
Boston
|
|
Scandal, Swine Flu, Shareholder Disputes, and More: 2009 Was Quite a Year for San Diego’s Life Sciences Industry
|
Denise Gellene |
12/22/09 |
San Diego
|
|
Biogen Idec Board in Flux, Cubist Acquires Calixa, ImmunoGen Drug Passes Clinical Test, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
12/16/09 |
Boston
|
|
New Faces, New Vacancies on Biogen Idec Board May Foretell Another Proxy Battle
|
Luke Timmerman |
12/15/09 |
Boston
|
|
Biogen Idec Chairman Steps Down as Board Re-Shuffles in Wake of Icahn Arrival
|
Luke Timmerman |
12/10/09 |
Boston
|
|
Biogen Idec Accused Again of Excessive CEO Pay, Lousy Performance, By Big Shareholder
|
Luke Timmerman |
11/20/09 |
Boston
|
|
Eastbourne Capital Dumps Entire Stake in Amylin After Partial Victory in Proxy Battle
|
Luke Timmerman |
10/09/09 |
San Diego
|
|
Amylin CEO, Putting Boardroom Coup Behind Him, Turns Up Heat on New Diabetes Drug
|
Luke Timmerman |
09/29/09 |
San Diego
|
|
Elan Breached Tysabri Partnership With Biogen Idec, Federal Judge Says
|
Luke Timmerman |
09/04/09 |
Boston
|
|
Pickett to Relinquish Biogen Idec Board Seat, New Financing for iWalk, Genocea Goes After Vaccine Market, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
09/02/09 |
Boston
|
|
Page 2 of
6 |
« previous page · next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.